Literature reported that RRM2 was a novel diagnostic marker and a potential therapeutic target in BLCA, but they just justified this result in a tissue microarray with IHC and conducted a single proliferation experiment in one BLCA cell line UMUC3 [50]. This evidence concerns the gene RRM2 and bladder transitional cell carcinoma.